Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

0.9121
+0.02292.58%
Volume:655.86K
Turnover:602.13K
Market Cap:113.10M
PE:-1.35
High:0.9386
Open:0.9200
Low:0.9086
Close:0.8892
52wk High:3.06
52wk Low:0.8841
Shares:124.00M
Float Shares:106.47M
Volume Ratio:0.59
T/O Rate:0.62%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6748
EPS(LYR):-0.7517
ROE:-35522.62%
ROA:-42.78%
PB:6.21
PE(LYR):-1.21

Loading ...

Mar 24, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 24, 2022

Major Issues Report

8-K - Current report
Mar 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2022

Correspondence

CORRESP [Cover] - Correspondence
Nov 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2021

Major Issues Report

8-K - Current report
Nov 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 05, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2021

Major Issues Report

8-K - Current report
Jun 02, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 17, 2021

Major Issues Report

8-K - Current report